We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

93 hedge funds and large institutions have $12.1M invested in Definium Therapeutics in 2023 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more call options, than puts

Call options by funds: $6.01M | Put options by funds: $1M

111% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 9

67% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 12

11% more funds holding

Funds holding: 84 → 93 (+9)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.32% less ownership

Funds ownership: 10.08% → 9.76% (-0.32%)

13% less capital invested

Capital invested by funds: $13.9M → $12.1M (-$1.75M)

Holders
93
Holders Change
+9
Holders Change %
+10.71%
% of All Funds
1.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
20
Reduced
12
Closed
9
Calls
$6.01M
Puts
$1M
Net Calls
+$5M
Net Calls Change
-$4M

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$797K
2
Millennium Management
Millennium Management
New York
+$785K
3
Citigroup
Citigroup
New York
+$358K
4
Group One Trading
Group One Trading
Illinois
+$347K
5
Citadel Advisors
Citadel Advisors
Florida
+$254K

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.85M
2
BB
Busey Bank
Illinois
-$156K
3
Renaissance Technologies
Renaissance Technologies
New York
-$130K
4
FCH
Freestone Capital Holdings
Washington
-$41K
5
BlackRock
BlackRock
New York
-$17.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
SIS
51
Strategic Investment Solutions
Illinois
$1.56K +$1.53K +372 +6,200%
PA
52
Parallel Advisors
California
$1.49K -$271 -66 -12%
TIM
53
Tortoise Investment Management
New York
$1.25K – – –
AFG
54
Albion Financial Group
Utah
$1.01K – – –
TFGT
55
TS Financial Group (TSFG)
Illinois
$1K – – –
EL
56
EMFO LLC
Florida
$939 – – –
HGERS
57
Householder Group Estate & Retirement Specialist
Arizona
$939 +$1.23K +300 New
Wells Fargo
58
Wells Fargo
California
$761 -$8 -2 -0.8%
Creative Planning
59
Creative Planning
Kansas
$683 +$896 +218 New
NA
60
NewEdge Advisors
Louisiana
$463 – – –
TRCT
61
Tower Research Capital (TRC)
New York
$416 +$547 +133 New
FFA
62
Farther Finance Advisors
California
$313 – – –
PGAM
63
Princeton Global Asset Management
New Jersey
$313 – – –
S
64
SignatureFD
Georgia
$213 +$271 +66 +3,300%
AF
65
Allworth Financial
California
$207 – – –
AF
66
Arrow Financial
New York
$207 – – –
HCM
67
Hollencrest Capital Management
California
$207 – – –
US Bancorp
68
US Bancorp
Minnesota
$207 – – –
WIM
69
Westside Investment Management
California
$207 – – –
TCM
70
Tradewinds Capital Management
Washington
$166 – – –
IPW
71
Impact Partnership Wealth
Georgia
$150 – – –
PMFA
72
Plante Moran Financial Advisors
Michigan
$113 – – –
FCA
73
FinTrust Capital Advisors
South Carolina
$104 – – –
CAM
74
Chesapeake Asset Management
New York
$103 – – –
IA
75
IFP Advisors
Florida
$94 – – –
1 2
3
4

DFTX Hedge Fund Activity: Q3 2023 in Review

93 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q3 2023, worth a combined $12.1M — down 13% from $13.9M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new DFTX positions and 9 closed out — a net gain of 10 holders — while 20 added to existing stakes and 12 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $797K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $2.85M sold.

  • 93 institutional investors held Definium Therapeutics (DFTX) as of Q3 2023, up from 84 in Q2 2023.
  • Funds reported $12.1M of Definium Therapeutics stock for Q3 2023, down 13% quarter-over-quarter.
  • 19 funds opened new Definium Therapeutics positions in Q3 2023 and 9 closed out, a net change of +10 holders.
  • The largest Definium Therapeutics buyer in Q3 2023 was Susquehanna International Group, an estimated $797K added.
  • The largest Definium Therapeutics seller in Q3 2023 was Alyeska Investment Group, an estimated $2.85M sold.

Based on aggregated 13F filings for Q3 2023.